SM934 treated lupus-prone NZB × NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development.
<h4>Background</h4>Artemisinin and its derivatives were reported to possess strong regulatory effects on inflammation and autoimmune diseases. This study was designed to examine the therapeutic effects and underlying mechanisms of SM934, a water-soluble artemisinin analogue, on lupus-pro...
Guardado en:
Autores principales: | Li-Fei Hou, Shi-Jun He, Xin Li, Chun-Ping Wan, Yang Yang, Xiao-Hui Zhang, Pei-Lan He, Yu Zhou, Feng-Hua Zhu, Yi-Fu Yang, Ying Li, Wei Tang, Jian-Ping Zuo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c5456729a7064a86821d9c88ed18c41e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fecal microbiota changes in NZB/W F1 mice after induction of lupus disease
por: Yen-Fu Chen, et al.
Publicado: (2021) -
Acta Nº934
por: Banco Central de Chile
Publicado: (2019) -
Elevated Serum Interleukin-34 Level in Patients with Systemic Lupus Erythematosus Is Associated with Disease Activity
por: Huan Huan Xie, et al.
Publicado: (2018) -
Death receptor 6 contributes to autoimmunity in lupus-prone mice
por: Daisuke Fujikura, et al.
Publicado: (2017) -
CD38 Correlates with an Immunosuppressive Treg Phenotype in Lupus-Prone Mice
por: Jocelyn C. Pérez-Lara, et al.
Publicado: (2021)